SCHEMBL9761856

SCHEMBL9761856

NCCCCc1nc(N2CCOCC2)[nH]c1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TSHR P16473 2/20 0.36
MEN1 O00255 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PIM1 P11309 1/20 0.35
ALDH1A1 P00352 5/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 3/20 0.33
CYP2C9 P11712 3/20 0.33
MAPT P10636 3/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 2/20 0.33
HPGD P15428 1/20 0.33
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9760948 0.77 CYP1A2 (0.36) KMT2ASMN1; SMN2MEN1ALDH1A1CYP1A2
SCHEMBL9761212 0.77 PARP1 (0.36) KMT2ASMN1; SMN2TSHRHSD17B10ALDH1A1
SCHEMBL9762538 0.74 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1CYP1A2CYP2C9MAPT
SCHEMBL9761124 0.73 KMT2A (0.52) KMT2ASMN1; SMN2TSHRMEN1HSD17B10
SCHEMBL9761268 0.73 CYP1A2 (0.37) KMT2ASMN1; SMN2MEN1ALDH1A1CYP1A2
SCHEMBL9762702 0.73 MAPT (0.33) ALDH1A1MAPT
SCHEMBL9761801 0.70 KMT2A (0.37) KMT2ASMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL9762396 0.69 MAPT (0.33) MAPT
SCHEMBL9761621 0.68 CYP1A2 (0.39) KMT2ASMN1; SMN2MEN1ALDH1A1CYP1A2
SCHEMBL9761459 0.66 ALDH1A1 (0.39) KMT2ASMN1; SMN2MEN1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026694-A Antitumor agents THE BRITISH COLUMBIA CANCER FOUNDATION (CA) 1991-06-25 US disclosed